Cargando…

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

BACKGROUND: We developed a novel risk scoring system for urothelial cancer (UC) patients receiving immune checkpoint inhibitors (ICI). METHODS: We conducted a retrospective review of 67 UC patients treated with ICI at Winship Cancer Institute of Emory University from 2015 to 2018. Using stepwise var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shabto, Julie M., Martini, Dylan J., Liu, Yuan, Ravindranathan, Deepak, Brown, Jacqueline, Hitron, Emilie E., Russler, Greta A., Caulfield, Sarah, Kissick, Haydn, Alemozaffar, Mehrdad, Ogan, Kenneth, Harris, Wayne B., Master, Viraj A., Kucuk, Omer, Carthon, Bradley C., Bilen, Mehmet A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163104/ https://www.ncbi.nlm.nih.gov/pubmed/32100417 http://dx.doi.org/10.1002/cam4.2932

Ejemplares similares

Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Martini, Dylan J., et al.
Publicado: (2019)

Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors
por: Brown, Jacqueline T, et al.
Publicado: (2021)

Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Zhuang, Tony Z, et al.
Publicado: (2022)

Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
por: Martini, Dylan J., et al.
Publicado: (2021)

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience
por: Martini, Dylan J., et al.
Publicado: (2022)

Metastatic Prostate Cancer Manifesting as Cholestatic Jaundice: A Case Report and Review of the Literature
por: Ravindranathan, Deepak, et al.
Publicado: (2018)

Ramucirumab and Docetaxel in Patients with Metastatic Urothelial Carcinoma Harboring Fibroblast Growth Factor Receptor Alterations: A Case Series and Literature Review
por: Smith, Katherine Emilie Rhoades, et al.
Publicado: (2020)

Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report
por: Bilen, Mehmet A., et al.
Publicado: (2021)

A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma
por: Sekar, Rishi R., et al.
Publicado: (2017)

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade
por: Olsen, T. Anders, et al.
Publicado: (2021)

Case Report: Exceptional Response to Nivolumab Plus Ipilimumab in a Young Woman With TFE3-SFPQ Fusion Translocation-Associated Renal Cell Carcinoma
por: Martini, Dylan J., et al.
Publicado: (2021)

Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma
por: Nazha, Bassel, et al.
Publicado: (2022)

Inflammatory Markers in Cancer Immunotherapy
por: Ravindranathan, Deepak, et al.
Publicado: (2021)

Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy
por: Baum, Yoram S., et al.
Publicado: (2016)

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy
por: Bilen, Mehmet Asim, et al.
Publicado: (2019)

Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy
por: Olsen, T. Anders, et al.
Publicado: (2022)

Detection of Microsatellite Instability via Circulating Tumor DNA and Response to Immunotherapy in Metastatic Castration-Resistant Prostate Cancer: A Case Series
por: Ravindranathan, Deepak, et al.
Publicado: (2021)

Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah’s witness: A case report
por: Zhuang, Tony Zibo, et al.
Publicado: (2022)

Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood
por: Carlisle, Jennifer Wilkinson, et al.
Publicado: (2022)

Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy
por: Bilen, Mehmet Asim, et al.
Publicado: (2019)

Identification of a Novel UT-B Urea Transporter in Human Urothelial Cancer
por: Hou, Ruida, et al.
Publicado: (2017)

Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database
por: Janopaul-Naylor, James Robert, et al.
Publicado: (2020)

Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival
por: Sekar, Rishi R., et al.
Publicado: (2016)

Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus
por: Master, Viraj A., et al.
Publicado: (2022)

Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy
por: Cross, Brian W., et al.
Publicado: (2012)

The immunosuppressive phenotype of tumor-infiltrating neutrophils is associated with obesity in kidney cancer patients
por: Margaroli, Camilla, et al.
Publicado: (2020)

External validation of the modified Glasgow prognostic score for renal cancer
por: Tai, Caroline G., et al.
Publicado: (2014)

Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [(68)Ga]Ga DOTATATE PET-CT
por: Bilen, Mehmet Asim, et al.
Publicado: (2022)

Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials
por: Zhuang, Tony Zibo, et al.
Publicado: (2022)

Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell renal cell carcinoma
por: Jansen, Caroline S., et al.
Publicado: (2023)

Data regarding covariates significantly associated with sarcopenia and varying albumin statuses in patients with renal cell carcinoma
por: Schmeusser, Benjamin N., et al.
Publicado: (2022)

Diagnosis, workup, and risk stratification of upper tract urothelial carcinoma
por: Zganjar, Andrew J., et al.
Publicado: (2023)

Extended lymph node dissection in robotic radical prostatectomy: Current status
por: Chopra, Sameer, et al.
Publicado: (2016)

Aquaporin-1 Protein Levels Elevated in Fresh Urine of Renal Cell Carcinoma Patients: Potential Use for Screening and Classification of Incidental Renal Lesions
por: Sreedharan, Shilpa, et al.
Publicado: (2014)

Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma
por: Khene, Zine-Eddine, et al.
Publicado: (2016)

Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab
por: Kobayashi, Takashi, et al.
Publicado: (2020)

PTP1B regulates lymphocytes responses androgen deprivation
por: Arredouani, Simo, et al.
Publicado: (2014)

Fragmented QRS for Risk Stratification in Patients Undergoing First Diagnostic Coronary Angiography
por: Eyuboglu, Mehmet, et al.
Publicado: (2016)

Clinic friendly estimation of muscle composition: Preoperative linear segmentation shows overall survival correlated with muscle mass in patients with nonmetastatic renal cell carcinoma
por: Schmeusser, Benjamin N., et al.
Publicado: (2022)

Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma
por: Liang, Fangfang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5bcf1dmvnvqj7maclofp6nhicq